Cargando…

Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor

BACKGROUND: Non-muscle invasive bladder cancer can be controlled by transurethral resection of bladder (TURB), but suffers from frequent recurrences in 60–70% of cases. Although, recurrence interval after TURB influences treatment course and prognosis, its implication and risk factors have not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Seung-hwan, Han, Jang Hee, Jeong, Chang Wook, Kim, Hyeon Hoe, Kwak, Cheol, Yuk, Hyeong Dong, Ku, Ja Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175350/ https://www.ncbi.nlm.nih.gov/pubmed/35676678 http://dx.doi.org/10.1186/s12885-022-09733-8

Ejemplares similares

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors
por: Lee, Kyeongchae, et al.
Publicado: (2022)

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
por: Kim, Byung Soo, et al.
Publicado: (2018)

Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
por: Kang, Minyong, et al.
Publicado: (2016)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?
por: Dangi, Anuj Deep, et al.
Publicado: (2018)

Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy
por: Han, Jang Hee, et al.
Publicado: (2022)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro
por: Kang, Minyong, et al.
Publicado: (2014)

Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
por: Ko, Kyungtae, et al.
Publicado: (2017)

High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy
por: Chung, Dae Hyuk, et al.
Publicado: (2023)

Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
por: Han, Jang Hee, et al.
Publicado: (2022)

Association between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs
por: Kang, Minyong, et al.
Publicado: (2016)

Lymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
por: Kim, Hyung Suk, et al.
Publicado: (2015)

The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy
por: Lee, Joong Sub, et al.
Publicado: (2015)

Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials
por: Quan, Yongjun, et al.
Publicado: (2017)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer
por: Breyer, Johannes, et al.
Publicado: (2017)

Urinary Markers for Bladder Cancer Diagnosis and Monitoring
por: Jeong, Seung-Hwan, et al.
Publicado: (2022)

External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Pyuria as an independent predictor of intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Lee, Jooho, et al.
Publicado: (2023)

Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis
por: Oh, Jong Jin, et al.
Publicado: (2019)

Prognostic Impact of Preoperative Renal Insufficiency on Metastasis-Free Survival after Radical Cystectomy
por: Suh, Jungyo, et al.
Publicado: (2021)

Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study
por: Seo, Gi Hyeon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fk8hsdkurqqa1srvvu45ungmjp